These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
641 related articles for article (PubMed ID: 19072422)
41. Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes. Johnson S J Infect; 2009 Jun; 58(6):403-10. PubMed ID: 19394704 [TBL] [Abstract][Full Text] [Related]
42. [Dramatic increase of Clostridium difficile-associated diarrhea in Germany: has the new strain PCR-ribotype 027 already reached us?]. Reichardt C; Chaberny IF; Kola A; Mattner F; Vonberg RP; Gastmeier P Dtsch Med Wochenschr; 2007 Feb; 132(5):223-8. PubMed ID: 17252365 [No Abstract] [Full Text] [Related]
43. Infection control measures to limit the spread of Clostridium difficile. Vonberg RP; Kuijper EJ; Wilcox MH; Barbut F; Tüll P; Gastmeier P; ; ; van den Broek PJ; Colville A; Coignard B; Daha T; Debast S; Duerden BI; van den Hof S; van der Kooi T; Maarleveld HJ; Nagy E; Notermans DW; O'Driscoll J; Patel B; Stone S; Wiuff C Clin Microbiol Infect; 2008 May; 14 Suppl 5():2-20. PubMed ID: 18412710 [TBL] [Abstract][Full Text] [Related]
44. Specific risk factors for Clostridium difficile-associated diarrhea: a prospective, multicenter, case control evaluation. Vesta KS; Wells PG; Gentry CA; Stipek WJ Am J Infect Control; 2005 Oct; 33(8):469-72. PubMed ID: 16216661 [TBL] [Abstract][Full Text] [Related]
45. Risk of Clostridium difficile infection after perioperative antibacterial prophylaxis before and during an outbreak of infection due to a hypervirulent strain. Carignan A; Allard C; Pépin J; Cossette B; Nault V; Valiquette L Clin Infect Dis; 2008 Jun; 46(12):1838-43. PubMed ID: 18462108 [TBL] [Abstract][Full Text] [Related]
46. [Role of Clostridium difficile infection in the relapse of ulcerative colitis]. Vilalta Castel E; Alcázar Montero MS; Navarro Gaspar C; Gimeno Aranguez M An Med Interna; 2002 Dec; 19(12):637-9. PubMed ID: 12593034 [TBL] [Abstract][Full Text] [Related]
47. Treatment of first recurrences of Clostridium difficile-associated disease: waiting for new treatment options. Louie TJ Clin Infect Dis; 2006 Mar; 42(6):765-7. PubMed ID: 16477550 [No Abstract] [Full Text] [Related]
48. Poor infection control, not fluoroquinolones, likely to be primary cause of Clostridium difficile-associated diarrhea outbreaks in Quebec. Weiss K Clin Infect Dis; 2006 Mar; 42(5):725-7; author reply 727-9. PubMed ID: 16447121 [No Abstract] [Full Text] [Related]
50. Is there a future for probiotics in preventing Clostridium difficile-associated disease and treatment of recurrent episodes? Imhoff A; Karpa K Nutr Clin Pract; 2009; 24(1):15-32. PubMed ID: 19244145 [TBL] [Abstract][Full Text] [Related]
51. Severe and refractory Clostridium difficile infection successfully treated with tigecycline and metronidazole. Lu CL; Liu CY; Liao CH; Huang YT; Wang HP; Hsueh PR Int J Antimicrob Agents; 2010 Mar; 35(3):311-2. PubMed ID: 20045292 [No Abstract] [Full Text] [Related]
52. [Epidemiological characteristics of nosocomial diarrhea caused by Clostridium difficile in a tertiary level hospital in Serbia]. Šuljagić V; Djordjević D; Lazić S; Mijović B Srp Arh Celok Lek; 2013; 141(7-8):482-9. PubMed ID: 24073554 [TBL] [Abstract][Full Text] [Related]
53. [Treatment of recurrent Clostridium difficile-associated diarrhoea with a suspension of donor faeces]. Nieuwdorp M; van Nood E; Speelman P; van Heukelem HA; Jansen JM; Visser CE; Kuijper EJ; Bartelsman JF; Keller JJ Ned Tijdschr Geneeskd; 2008 Aug; 152(35):1927-32. PubMed ID: 18808083 [TBL] [Abstract][Full Text] [Related]
54. Drug evaluation: OPT-80, a narrow-spectrum macrocyclic antibiotic. Johnson AP Curr Opin Investig Drugs; 2007 Feb; 8(2):168-73. PubMed ID: 17328233 [TBL] [Abstract][Full Text] [Related]
55. [High incidence and complications of Clostridium difficile diarrhea among patients with renal diseases]. Herrera P; Cotera A; Fica A; Galdo T; Alvo M Rev Med Chil; 2003 Apr; 131(4):397-403. PubMed ID: 12870234 [TBL] [Abstract][Full Text] [Related]
56. [Old dogmas and new perspectives in antibiotic-associated diarrhea]. Cramer JP; Burchard GD; Lohse AW Med Klin (Munich); 2008 May; 103(5):325-38; quiz 339-40. PubMed ID: 18484219 [TBL] [Abstract][Full Text] [Related]
57. Frequent emergence of resistance in Clostridium difficile during treatment of C. difficile-associated diarrhea with fusidic acid. Norén T; Wullt M; Akerlund T; Bäck E; Odenholt I; Burman LG Antimicrob Agents Chemother; 2006 Sep; 50(9):3028-32. PubMed ID: 16940098 [TBL] [Abstract][Full Text] [Related]
58. Surveillance for community-associated Clostridium difficile--Connecticut, 2006. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2008 Apr; 57(13):340-3. PubMed ID: 18385641 [TBL] [Abstract][Full Text] [Related]
59. [Clostridium difficile-associated diarrhea--a growing problem in geriatric care]. Cederholm T; Larsson J; Ericsson O; Myrbäck KE; Hellgren U Lakartidningen; 2001 Feb; 98(8):833-7. PubMed ID: 11265569 [TBL] [Abstract][Full Text] [Related]
60. Multiple relapses of Clostridium difficile-associated diarrhea in a cancer patient. Successful control with long-term cholestyramine therapy. Moncino MD; Falletta JM Am J Pediatr Hematol Oncol; 1992 Nov; 14(4):361-4. PubMed ID: 1456403 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]